Insert Cover Image using Slide Master View                             Do not distortAnti-Diabetic Pharmaceuticals Market ...
Executive Summary                   Anti-diabetic pharmaceuticals market in India is valued at INR 22.54 bn in 2010    Mar...
•Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Drug Regulation and Patents•Competition•Strategi...
India’s diabetes market is poised to grow over the coming years Indian Market – Overview                                  ...
Drivers & Challenges                                                                          Challenges  Drivers         ...
Various initiatives taken by the government is providing a boost to this market                      • ICDC ,registered un...
Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information                               ...
Thank you for the attentionThe Anti-Diabetic Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndust...
Upcoming SlideShare
Loading in...5
×

Anti-diabetic Pharmaceuticals Market in India - Sample

2,411

Published on

Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Anti-Diabetic Pharmaceuticals Market in India 2011 report. India being the second largest diabetic pool in the world, the market is expected to show steady growth in the coming years.

The report begins with the introduction section which offers a brief classification of the different types of diabetes. It then gives a classification of the diabetes market, and then provides a brief description of different classes of diabetes pharmaceuticals. The market overview section provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. It also provides a global diabetes map.

An analysis of the drivers explains the factors for growth of the industry including increasing diabetes cases, introduction of newer and better drugs, increasing aging population and increase in health insurance policies. The key challenges include price regulation in the insulin market, competition from use of complementary and alternative medicines and maintainence of a healthy lifestyle to avoid diabetes.

The government initiatives section gives a brief description of the different diabetes programmes undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for diabetes drugs.

The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,411
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
128
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Anti-diabetic Pharmaceuticals Market in India - Sample

  1. 1. Insert Cover Image using Slide Master View Do not distortAnti-Diabetic Pharmaceuticals Market - IndiaAugust 2011
  2. 2. Executive Summary Anti-diabetic pharmaceuticals market in India is valued at INR 22.54 bn in 2010 Market Market is expected to grow at a CAGR of 11% from 2010 to 2015 Anti-diabetes therapeutic segment is the second fastest growing segment, after oncology Drivers: Challenges: Increase in the number of diabetic Price regulation in insulin market patients Use of complementary and alternative medicines E Drivers and Introduction of newer and better drugs L Challenges Maintainence of healthy lifestyle to avoid Increasing aging population diabetes covering diabetes MP Comprehensive health insurances policies SA Phases of clinical trialDrug regulation Approval and licensing of drugs and patents Patents Highly fragmented market with large number of players Competition Major foreign players in the market include Novo Nordisk, Eli Lilly and Glaxosmithkline Major domestic companies include Panacea Biotech, Strides Arcolab, Torrent Pharmaceuticals, Ranbaxy, Dr. Reddy’s, Cipla, Sun Pharmaceuticals, among others Strategic Foray into the insulin delivery marketrecommendations Collaboration with private hospitals ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 2
  3. 3. •Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Drug Regulation and Patents•Competition•Strategic recommendation ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 3
  4. 4. India’s diabetes market is poised to grow over the coming years Indian Market – Overview Market Size and Growth • India is considered to be one of the most lucrative diabetes markets in the world INR bn • Anti-diabetics represent the second fastest growing y% F therapeutic segment among all the segments ,after 40 E D oncology 30 B C • Market is expected to grow from INR A bn to INR B bn A in 20--, at a CAGR of y% 20 • Biguanides, Gliclazide, Gliclazide with metformine, 10 Rosiglitazone and Pioglitazone are the top selling drugs in Indian market • Human Mixard 30/70 is the largest selling insulin in Indian market It showed largest growth among the top 10 brands in Indian PLE 0 2010 2011e 2012e 2013e 2014e 2015e M Pharmaceutical market A Growth in therapeutic segments(2010) Market Segmentation oncology diabetes 0 5 10 15 20 25 b 30 S35 a % X1 Drugs Insulin Y2 CVS c X2 CNS d Y1 respiratory e pain f gastro ganti-infectives hSource: ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 4
  5. 5. Drivers & Challenges Challenges Drivers Price regulation in insulin market Increase in the number of diabetic Competition from complementary and patients alternative medicines Introduction of newer and better Maintainence of healthy lifestyle to drugs avoid diabetes Increasing aging population Increase in health insurances ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 5
  6. 6. Various initiatives taken by the government is providing a boost to this market • ICDC ,registered under Planning Commission, Government of India, is the only organisation in India providing doorstep diabetes care • ICDC implements National Doorstep Diabetes Identification and follow-up programme through Grass Root Level NGOs all over India Indian Council for • ICDC affiliates NGOs as Partner Organisation and reach people who are suffering with Diabetes and help Diabetic Care them to control diabetes and live without any complications • ICDC provides free glucometer and 100 Strips to the NGOs to start identifying the diabetes patients even in villages • ICDC is making efforts to provide medical insurance to the diabetes patients through Government of India LE as in the case of family planning insurance scheme MP • National Programme for prevention and Control of Diabetes, Cardiovascular diseases and Stroke (NPCDCS) was started in 2008,with the objective of prevention, diagnosis and early NPCDCS management of diabetes SA • It is already being implemented in 100 most backward and remote districts spread across 21 states • Indian Government plans to extend this programme to all the 650 districts of the country under the 12th five year plan • National Rural Health Mission is providing services for diabetes care in rural India NRHM • Seeks to provide effective healthcare to rural population throughout the country with special focus on 18 statesSource: ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 6
  7. 7. Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information Financial Performance Revenue Revenue Profit Headquarters City 1, country 1 INR tn INR bn Profit / Loss Founded 19-- 3 2.0 r2 r3 r4 r1 1.5 2 Products Product 1, product 2, product 3 1.0 1 LE 0.5 Key People Person X, CEO 0 0.0 Business Highlights MP 2007 2008 2009 2010 • Company employs around n people SA • Product portfolio includes prescription products in various therapeutic areas, segment A, segment B, segment C • Anti-diabetes products include Product 1, Product 2, Product 3 • Company has collaboration agreements with Institute YSource: Note: Figures are for year ending 31st December ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 7
  8. 8. Thank you for the attentionThe Anti-Diabetic Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndustry Series.For more detailed information or customized research requirements please contact:Tamojit Roy Gagan UppalPhone: +91 33 4064 6215 Phone: +91 22 4098 7530E-Mail: tamojit.roy@netscribes.com E-Mail: gagan.uppal@netscribes.comResearch on India is a product of Netscribes (India) Pvt. Ltd. Research on India is dedicated to disseminating information and providing quickinsights on “hot” industries in India and other emerging markets. Track our new releases and major updates in these industries onAbout NetscribesNetscribes is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a truevalue proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients’ profitability and growthobjectives.Disclaimer: This report is published for general information only. Although high standards have been used the preparation, Research on India,Netscribes (India) Pvt. Ltd. or “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is thesole property of Netscribes (India) Pvt. Ltd. and prior permission is required for guidelines on reproduction. ANTI-DIABETES PHARMACEUTICALS MARKET 2011.PPT 8
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×